Stanley Laman Group Ltd. lowered its stake in shares of Schrödinger, Inc. (NASDAQ:SDGR - Free Report) by 14.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 197,668 shares of the company's stock after selling 33,556 shares during the quarter. Stanley Laman Group Ltd. owned 0.27% of Schrödinger worth $3,667,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Nisa Investment Advisors LLC grew its position in Schrödinger by 145.3% during the second quarter. Nisa Investment Advisors LLC now owns 1,413 shares of the company's stock valued at $27,000 after acquiring an additional 837 shares during the last quarter. GAMMA Investing LLC raised its position in Schrödinger by 49.5% in the 2nd quarter. GAMMA Investing LLC now owns 2,124 shares of the company's stock worth $41,000 after purchasing an additional 703 shares during the period. nVerses Capital LLC purchased a new position in Schrödinger in the 2nd quarter worth $66,000. PNC Financial Services Group Inc. lifted its stake in Schrödinger by 186.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 2,127 shares of the company's stock worth $76,000 after purchasing an additional 1,385 shares during the last quarter. Finally, Quest Partners LLC boosted its position in Schrödinger by 1,005.6% during the second quarter. Quest Partners LLC now owns 4,555 shares of the company's stock valued at $88,000 after buying an additional 4,143 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on SDGR shares. Leerink Partners began coverage on Schrödinger in a research note on Tuesday, July 2nd. They issued an "outperform" rating and a $29.00 target price for the company. Leerink Partnrs raised Schrödinger to a "strong-buy" rating in a research note on Tuesday, July 2nd. KeyCorp decreased their target price on shares of Schrödinger from $30.00 to $25.00 and set an "overweight" rating on the stock in a research note on Thursday, July 11th. Morgan Stanley dropped their price target on shares of Schrödinger from $43.00 to $30.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 21st. Finally, BMO Capital Markets decreased their price objective on shares of Schrödinger from $30.00 to $25.00 and set an "outperform" rating on the stock in a research report on Thursday, October 17th. Three research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $32.60.
Check Out Our Latest Stock Report on Schrödinger
Insider Activity at Schrödinger
In related news, insider Margaret Dugan sold 1,531 shares of the firm's stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $17.78, for a total transaction of $27,221.18. Following the completion of the transaction, the insider now owns 13,469 shares of the company's stock, valued at $239,478.82. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 8.60% of the stock is currently owned by corporate insiders.
Schrödinger Price Performance
SDGR stock traded down $0.56 during trading on Wednesday, reaching $18.12. The company had a trading volume of 882,943 shares, compared to its average volume of 746,983. The business has a 50 day moving average of $19.27 and a 200 day moving average of $21.14. The company has a market cap of $1.32 billion, a P/E ratio of -6.97 and a beta of 1.50. Schrödinger, Inc. has a 52 week low of $16.67 and a 52 week high of $38.00.
Schrödinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The company reported ($0.74) earnings per share for the quarter, beating the consensus estimate of ($0.85) by $0.11. The company had revenue of $47.33 million for the quarter, compared to analyst estimates of $40.19 million. Schrödinger had a negative return on equity of 38.38% and a negative net margin of 100.42%. Research analysts expect that Schrödinger, Inc. will post -2.19 earnings per share for the current year.
About Schrödinger
(
Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Featured Articles
Before you consider Schrödinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.
While Schrödinger currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.